Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Drug Copay Assistance Launched for Hepatitis C Patients

By The Assistance Fund | December 14, 2016

Patient advocate offering assistance to families. (Credit: The Assistance Fund)

The Assistance Fund introduces copay assistance program for Hepatitis C patients.

The Assistance Fund, an independent charitable patient assistance foundation that helps patients and families facing high medical out-of-pocket costs, announced that it will provide financial support for patients with Hepatitis C through its Copay Assistance Program. The Hepatitis C Copay Assistance Program offers eligible patients financial aid for copays, coinsurance and deductibles for FDA-approved prescription medications.

“The Assistance Fund is pleased to be able to provide much-needed financial support for patients diagnosed with Hepatitis C,” said Mark P. McGreevy, president, The Assistance Fund. “Treatment options for chronic Hepatitis C have evolved greatly in recent years, but many still lack access to these medications due to financial barriers. It’s critical that patients be able to receive these new treatments regardless of their ability to pay.”

Hepatitis C, one of several hepatitis viruses, is a disease of the liver that affects an estimated 2.7 – 3.9 million Americans.1 While some patients have acute Hepatitis C, which goes away on its own after a few months, most suffer from chronic (long-term) Hepatitis C. The disease shows few or no signs in the early stages, and many don’t realize they have it until they have sustained liver damage for years or even decades. If left untreated, Hepatitis C can cause serious health problems for the liver, including cirrhosis, liver cancer and liver failure.2

“At The Assistance Fund, our focus is ensuring that patients who have been prescribed Hepatitis C treatments by their medical teams do not face a financial barrier to access,” said Gerald Lauria, vice president of business development and strategic initiatives, The Assistance Fund. “The Hepatitis C Copay Assistance Program will provide crucial support to patients who may otherwise struggle to afford treatment.”

Individuals interested in learning more or determining their eligibility for assistance should visit tafcares.org or call 855.730.5873 to speak with a patient advocate.

A list of all the funds available at The Assistance Fund can be found at tafcares.org/patients/apply. New funds can open and close at any time as funds are allocated to patients in need of assistance and new funds become available. Patients are encouraged to frequently check the status of the fund for their disease area if they are seeking financial assistance.

The Assistance Fund is an independent charitable patient assistance foundation that helps patients and families facing high medical out-of-pocket costs by providing financial assistance for their copayments, coinsurance, deductibles and other health-related expenses. The foundation currently manages more than 30 funds — each of which covers the FDA-approved medications that treat a specific disease. Since its founding in 2009, it has helped more than 43,000 adults and children access the medicines they need. tafcares.org.
__________________________________________________
References:

1 “Hepatitis C FAQs for Health Professionals.” Centers for Disease Control and Prevention. 2016, December. Retrieved from http://www.cdc.gov/hepatitis/hcv/hcvfaq.htm.

2 “Hep C 123.” American Liver Foundation. 2016, December. Retrieved from http://hepc.liverfoundation.org/what-is-hepatitis-c/.

(Source: Business Wire)

Related Articles Read More >

MGS opens 300,000-square-foot Wisconsin facility to scale drug delivery device manufacturing
This is a Fujifilm Biotechnologies image of its northeast England campus.
Fujifilm Biotechnologies expands in U.K.
From automation islands to connected plants: A roadmap for pharma manufacturers
This is the logo of Johnson & Johnson.
Johnson & Johnson announces new North Carolina pharma plant
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2026 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE